| 810 | 13 | 51 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探索营养干预对非小细胞肺癌患者化疗期间营养状况的影响。方法 选取2020年11月—2021年10月在医院肿瘤科及呼吸科就诊的首次进行化疗的108例肺癌患者为研究对象，随机分为口服营养补充组和对照组，口服营养补充组给予个体化营养教育和口服补充营养素，对照组给予常规治疗和饮食指导，评估营养干预对非小细胞肺癌患者的患者主观整体评分、部分生化指标和人体成分指标的影响。结果 在4个化疗周期期间，患者主观整体评分呈不断上升趋势且从第2周期开始口服营养补充组评分均低于对照组，差异无统计学意义；化疗第2周期开始至第4周期结束，口服营养补充组白细胞、总淋巴细胞、血红蛋白、总蛋白、白蛋白均优于对照组，差异有统计学意义(P<0.05);第2周期开始至第4周期结束口服营养补充组的体重、体质指数、蛋白质、骨骼肌含量、去脂体重均高于对照组，差异有统计学意义(P<0.05)。结论 非小细胞肺癌患者在4个化疗周期营养状况明显下降，及时给予营养干预可以改善或维持身体成分的正常水平，提升综合治疗效果。
Abstract：[1] World Health Organization Lung Cancer[EB/OL][2021-10-10].http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
[2] SONG C,CAO J,ZHANG F,et al.Nutritional risk assessment by scored patient-generated subjective global assessment associated with demographic characteristics in 23,904 common malignant tumors patients[J].Nutr Cancer,2019,71(1):50-60.
[3] 中国营养学会肿瘤营养管理分会.中国肿瘤患者膳食营养白皮书(2020-2021)[M].北京：人民卫生出版社，2020.
[4] NIGRO E,PERROTTA F,SCIALò F,et al.Food,nutrition,physical activity and microbiota:which impact on lung cancer?[J].Int J Environ Res Public Health,2021,18(5):2399.
[5] KHAN S,ALIBAY TA,MERAD M,et al.Detection and evaluation of malnutrition in oncology:What tools,what type of cancer and for what purposes?[J].Bull Cancer,2016,103(9):776-785.
[6] KEANE N,FRAGKOS K C,PATEL P S,et al.Performance status,prognostic scoring,and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition[J].Nutr Cancer,2018,70:73-82.
[7] WANG Z K,YANG Y S,STEFKA A T,et al.Review article:fungal microbiota and digesitive diseases[J].Aliment Pharmacol Ther,2014,39(8):751-766.
[8] LIN T,YANG J,HONG X,et al.Nutritional status in patients with advanced lung cancer undergoing chemotherapy:a prospective observational study[J].Nutr Cancer,2020,72(7):1225-1230.
[9] MELE MC,RINNINELLA E,CINTONI M,et al.Nutritional support in lung cancer patients:the state of the art[J].Clin Lung Cancer,2021,22(4):e584-e594.
[10] YANG J,ZHANG Q,WANG X.Role of nutritional support for postoperative recovery of respiratory function in patients with primary lung cancer[J].Oncol Lett,2018,16:5978-5982.
[11] 中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会(CSCO)恶性肿瘤患者营养治疗指南2021[M].北京：人民卫生出版社，2021.
[12] 孙岩波，陈永平，李树民，等.谷氨酰胺联合益生菌对腹部大手术后病人早期肠屏障损伤及细菌移位的影响[J].肠外与肠内营养，2020,27(5):265-269.
[13] ROSSI S,DI NOIA V,TONETTI L,et al.Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?[J].Future Oncol,2018,14:919-926.
[14] MOREL H,RAYNARD B,ARLHAC M,et al.Prediagnosis weight loss,a stronger factor than BMI,to predict survival in patients with lung cancer[J].Lung Cancer,2018,126:55-63.
[15] MOHAN A,POULOSE R,ANSARI A,et al.Alterations in body composition in Indian patients with non-small cell lung cancer[J].Lung India,2019,36(4):295-298.
[16] DE CARVALHO T M,MIGUEL MARIN D,DA SILVA C A,et al.Evaluation of patients with head and neck cancer performing standard treatment in relation to body composition,resting metabolic rate,and inflammatory cytokines [J].Head Neck,2015,37(1):97-102.
基本信息:
DOI：10.19813/j.cnki.weishengyanjiu.2022.02.025
中图分类号:R734.2;R459.3
引用信息:
[1]刘宝瑜,任朝旭,刘庆涛,等.营养干预对非小细胞肺癌患者化疗期间营养状况的影响[J].卫生研究,2022,51(02):325-328+335.DOI:10.19813/j.cnki.weishengyanjiu.2022.02.025.
2022-03-26
2022-03-26